Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.38 trillion and total revenue of $115.79 billion.
Market Cap
1.38T
Revenue
115.79B
Profits
-39.07B
PE Ratio
n/a
Profit Margin
-33.74%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 141.11B | 1.66% | 1,734,757 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 85.08B | 3.42% | 749,453 | 15.53B |
| 3 | ARGX | argenx SE | 65.29B | 2.61% | 216,992 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 60.21B | -2.24% | 16,563,189 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.85B | -0.30% | 1,333,392 | - |
| 6 | ONC | BeOne Medicines AG | 41.14B | 0.87% | 295,204 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 36.29B | 1.27% | 3,143,775 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 35.78B | 8.65% | 3,286,329 | 4.80B |
| 9 | INSM | Insmed Incorporated | 27.65B | 4.21% | 1,998,835 | 1.14B |
| 10 | INCY | Incyte Corporation | 26.11B | 3.06% | 2,324,205 | 5.82B |
| 11 | BNTX | BioNTech SE | 26.08B | 1.82% | 753,654 | 3.03B |
| 12 | ROIV | Roivant Sciences Ltd. | 24.69B | -0.98% | 6,196,078 | 7.53M |
| 13 | GMAB | Genmab A/S | 20.14B | 2.78% | 2,079,451 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.56B | 2.71% | 418,296 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.94B | 0.76% | 1,155,956 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.96B | -0.09% | 1,620,739 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.50B | 2.88% | 2,851,454 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 12.96B | 3.29% | 2,521,399 | 3.41B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.64B | 1.53% | 202,818 | 1.28B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.45B | 1.80% | 1,619,588 | 1.66B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | 3.18% | 1,525,567 | 669.50M |
| 22 | CORT | Corcept Therapeutics Incorporated | 11.94B | -2.60% | 960,830 | 830.81M |
| 23 | SMMT | Summit Therapeutics Inc. | 11.65B | 3.11% | 3,779,231 | - |
| 24 | TECH | Bio-Techne Corporation | 11.34B | 0.17% | 1,655,845 | 1.22B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 11.00B | 3.50% | 608,189 | 776.57M |
| 26 | KRYS | Krystal Biotech, Inc. | 10.93B | 1.48% | 305,202 | 440.48M |
| 27 | ABVX | ABIVAX Société Anonyme | 10.48B | -2.28% | 868,278 | 5.67M |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 10.19B | 2.42% | 1,845,866 | 874.09M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.19B | -0.01% | 5,142,068 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 10.00B | 0.74% | 1,605,680 | 67.67M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 9.98B | 1.15% | 289,403 | 7.46M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.86B | -0.35% | 982,968 | 105.00M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.45B | -0.28% | 561,612 | 281.99M |
| 34 | PCVX | Vaxcyte, Inc. | 9.16B | 1.27% | 1,021,291 | - |
| 35 | IBRX | ImmunityBio, Inc. | 8.43B | 1.02% | 7,228,321 | 165.79M |
| 36 | IMVT | Immunovant, Inc. | 8.16B | -1.03% | 1,331,015 | - |
| 37 | TGTX | TG Therapeutics, Inc. | 8.07B | 1.44% | 2,361,895 | 799.54M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.68B | -1.64% | 1,361,713 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.26B | 0.65% | 455,592 | 239.92M |
| 40 | CAI | Caris Life Sciences, Inc. | 7.01B | 0.08% | 5,488,363 | 989.61M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.83B | 0.38% | 1,065,938 | - |
| 42 | CGON | CG Oncology, Inc. | 6.61B | -1.67% | 663,885 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.48B | 1.52% | 495,626 | 618.07M |
| 44 | BLTE | Belite Bio, Inc | 6.47B | 2.53% | 212,682 | - |
| 45 | TVTX | Travere Therapeutics, Inc. | 6.34B | 2.31% | 1,085,747 | 591.33M |
| 46 | ORKA | Oruka Therapeutics, Inc. | 6.07B | -0.52% | 672,355 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 6.00B | -0.32% | 1,181,784 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.99B | 1.74% | 902,585 | 1.01B |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 5.94B | -0.36% | 565,394 | 1.90M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.27% | 637,203 | 7.50M |
| 51 | ERAS | Erasca, Inc. | 5.73B | -2.33% | 5,121,428 | - |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | 0.93% | 189,615 | 290.54M |
| 53 | CRSP | CRISPR Therapeutics AG | 5.50B | 0.18% | 911,121 | 13.39M |
| 54 | DFTX | Definium Therapeutics, Inc. | 5.23B | 1.04% | 1,429,217 | - |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | 0.14% | 1,555,986 | 1.14B |
| 56 | PBLS | Parabilis Medicines, Inc. | 4.95B | 1.62% | 363,945 | 148.00K |
| 57 | CELC | Celcuity Inc. | 4.71B | 4.59% | 819,183 | - |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.69B | 0.16% | 2,181,230 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.56B | -0.64% | 1,003,521 | - |
| 60 | ELVN | Enliven Therapeutics, Inc. | 4.32B | 1.99% | 609,969 | - |
| 61 | LEGN | Legend Biotech Corporation | 4.24B | 3.60% | 1,479,044 | 1.27B |
| 62 | MANE | Veradermics, Incorporated | 4.11B | 0.97% | 427,304 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.06B | 0.11% | 2,107,874 | 10.35M |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.91B | -0.50% | 1,573,316 | - |
| 65 | IOVA | Iovance Biotherapeutics, Inc. | 3.90B | 4.11% | 12,393,158 | 324.97M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.88B | 0.55% | 765,286 | 234.13M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.82B | 5.53% | 239,369 | 890.79M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.80B | 0.47% | 1,233,715 | 117.00M |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.76B | -0.13% | 1,916,707 | 53.81M |
| 70 | ABCL | AbCellera Biologics Inc. | 3.68B | 0.71% | 3,726,311 | 66.17M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.65B | -1.80% | 1,768,603 | 3.60M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.63B | 11.76% | 1,899,864 | 606.33M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.41B | 1.42% | 1,064,738 | - |
| 74 | QURE | uniQure N.V. | 3.21B | -3.41% | 2,485,971 | 18.67M |
| 75 | IMNM | Immunome, Inc. | 3.10B | 0.96% | 811,104 | 4.02M |
| 76 | CLDX | Celldex Therapeutics, Inc. | 3.10B | 0.61% | 476,586 | 158.00K |
| 77 | IRON | Disc Medicine, Inc. | 3.07B | 1.75% | 522,550 | - |
| 78 | NAMS | NewAmsterdam Pharma Company N.V. | 3.06B | 2.69% | 979,908 | 7.12M |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | 0.42% | 1,950,718 | 463.98M |
| 80 | ZLAB | Zai Lab Limited | 2.97B | 4.66% | 1,056,852 | 449.61M |
| 81 | MBX | MBX Biosciences, Inc. | 2.93B | -0.07% | 352,286 | - |
| 82 | BEAM | Beam Therapeutics Inc. | 2.93B | 0.93% | 1,293,354 | 156.04M |
| 83 | SLS | SELLAS Life Sciences Group, Inc. | 2.86B | 7.11% | 6,236,339 | - |
| 84 | ATAI | AtaiBeckley Inc. | 2.73B | 0.14% | 10,454,999 | 4.47M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -0.84% | 1,736,081 | 36.77M |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.61B | 2.79% | 7,170,810 | 717.00M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.58B | -1.09% | 1,417,445 | 71.13M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.57B | 4.18% | 1,756,873 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | 13.57% | 2,039,901 | - |
| 90 | PGEN | Precigen, Inc. | 2.51B | 2.19% | 2,638,059 | 85.72M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.50B | 3.90% | 1,167,448 | 959.90M |
| 92 | NKTR | Nektar Therapeutics | 2.48B | 1.38% | 353,957 | 54.59M |
| 93 | PHVS | Pharvaris N.V. | 2.47B | 0.69% | 320,877 | - |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 2.45B | 8.81% | 4,807,158 | 1.97B |
| 95 | NUVB | Nuvation Bio Inc. | 2.43B | 4.37% | 4,997,645 | 169.90M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 2.43B | 2.90% | 1,350,083 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 3.12% | 2,068,791 | 52.06M |
| 98 | BHVN | Biohaven Ltd. | 2.37B | -0.32% | 2,679,470 | - |
| 99 | KOD | Kodiak Sciences Inc. | 2.35B | 1.19% | 507,491 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.34B | 0.27% | 294,754 | 20.00M |
| 101 | MESO | Mesoblast Limited | 2.22B | 4.79% | 296,627 | 120.25M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 1.59% | 125,223 | - |
| 103 | ZYME | Zymeworks Inc. | 2.20B | 4.65% | 808,099 | 37.13M |
| 104 | URGN | UroGen Pharma Ltd. | 2.17B | 2.37% | 473,500 | 188.73M |
| 105 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | 1.50% | 842,415 | 311.51M |
| 106 | ZBIO | Zenas BioPharma, Inc. | 2.16B | 3.60% | 757,494 | 1.00M |
| 107 | ADMA | ADMA Biologics, Inc. | 2.13B | 1.93% | 1,989,638 | 512.28M |
| 108 | VCEL | Vericel Corporation | 2.09B | 0.96% | 395,530 | 306.30M |
| 109 | GENB | Generate Biomedicines, Inc. | 2.09B | 3.10% | 892,644 | 26.48M |
| 110 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | 1.54% | 325,208 | - |
| 111 | NBTX | Nanobiotix S.A. | 2.07B | 6.06% | 185,265 | 38.27M |
| 112 | KLRA | Kailera Therapeutics, Inc. | 2.05B | -3.41% | 737,266 | - |
| 113 | KARD | Kardigan, Inc. | 2.05B | 11.84% | 354,922 | - |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | -0.23% | 771,682 | 98.34M |
| 115 | XNCR | Xencor, Inc. | 2.00B | -3.62% | 1,018,293 | 104.97M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.97B | -1.26% | 631,318 | 27.59M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.95B | -1.12% | 3,019,932 | 303.23M |
| 118 | GHRS | GH Research PLC | 1.93B | 2.60% | 111,854 | - |
| 119 | IMCR | Immunocore Holdings plc | 1.92B | 1.38% | 220,689 | 430.78M |
| 120 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 1.10% | 3,668,981 | 208.78M |
| 121 | SLBT | SL Science Holding Limited | 1.89B | 18.64% | 116,616 | 3.27M |
| 122 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.91% | 215,155 | 1.13B |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | 3.38% | 2,016,197 | 252.25M |
| 124 | INBX | Inhibrx Biosciences, Inc. | 1.84B | 0.25% | 189,886 | 1.30M |
| 125 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | -1.05% | 1,988,568 | 5.49M |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.81B | 1.50% | 14,052,683 | 54.86M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 0.55% | 3,245,595 | 59.51M |
| 128 | SEPN | Septerna, Inc. | 1.75B | -0.48% | 263,248 | 98.88M |
| 129 | FTRE | Fortrea Holdings Inc. | 1.75B | 3.61% | 902,450 | 2.68B |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.74B | 0.14% | 462,946 | - |
| 131 | BRVE | Braveheart Bio, Inc. | 1.73B | 2.55% | 394,506 | - |
| 132 | NVAX | Novavax, Inc. | 1.70B | 1.98% | 5,635,818 | 413.80M |
| 133 | ANAB | AnaptysBio, Inc. | 1.65B | 1.01% | 421,732 | 232.39M |
| 134 | TRAX | First Tracks Biotherapeutics, Inc. | 1.62B | 9.98% | 1,365,290 | - |
| 135 | LBRX | LB Pharmaceuticals Inc | 1.60B | 5.05% | 518,387 | - |
| 136 | AVLN | Avalyn Pharma Inc. | 1.58B | 0.85% | 181,852 | - |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.56B | 0.60% | 518,794 | - |
| 138 | INVA | Innoviva, Inc. | 1.54B | 1.28% | 600,599 | 440.00M |
| 139 | APMD | Apnimed, Inc. | 1.54B | 3.65% | 276,563 | 120.15M |
| 140 | AAPG | Ascentage Pharma Group International | 1.53B | 3.57% | 2,482 | 94.61M |
| 141 | ABSI | Absci Corporation | 1.51B | -0.45% | 2,951,546 | 1.56M |
| 142 | REPL | Replimune Group, Inc. | 1.51B | 1.98% | 1,989,600 | - |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.50B | 1.19% | 423,869 | - |
| 144 | TYRA | Tyra Biosciences, Inc. | 1.50B | -0.67% | 567,917 | - |
| 145 | AKTS | Aktis Oncology, Inc. | 1.50B | 3.58% | 253,451 | 10.06M |
| 146 | MAZE | Maze Therapeutics, Inc. | 1.48B | 0.72% | 440,698 | 20.00M |
| 147 | VOR | Vor Biopharma Inc. | 1.46B | 9.36% | 824,988 | - |
| 148 | ANRO | Alto Neuroscience, Inc. | 1.44B | 4.09% | 432,780 | - |
| 149 | CGEM | Cullinan Therapeutics, Inc. | 1.44B | 2.48% | 769,693 | - |
| 150 | SVRA | Savara Inc. | 1.39B | 2.06% | 1,216,895 | - |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.38B | -2.20% | 163,229 | - |
| 152 | OMER | Omeros Corporation | 1.37B | 0.59% | 1,350,615 | 38.42M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.36B | 1.81% | 506,170 | - |
| 154 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | 1.86% | 1,546,227 | - |
| 155 | MGTX | MeiraGTx Holdings plc | 1.35B | -0.92% | 629,372 | 397.50M |
| 156 | ALMS | Alumis Inc. | 1.34B | 9.29% | 10,382,833 | 7.40M |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 5.51% | 156,427 | - |
| 158 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 2.65% | 372,477 | - |
| 159 | MNKD | MannKind Corporation | 1.30B | 1.51% | 2,590,709 | 393.63M |
| 160 | IMTX | Immatics N.V. | 1.30B | 0.74% | 761,070 | 47.65M |
| 161 | MLTX | MoonLake Immunotherapeutics | 1.28B | -0.46% | 1,188,555 | - |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 1.28B | 8.65% | 171,404 | 99.00K |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -0.63% | 1,530,365 | 28.73M |
| 164 | JANX | Janux Therapeutics, Inc. | 1.20B | 4.29% | 1,525,676 | 24.00M |
| 165 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -0.49% | 619,857 | - |
| 166 | KURA | Kura Oncology, Inc. | 1.17B | 1.71% | 1,884,836 | 77.23M |
| 167 | SANA | Sana Biotechnology, Inc. | 1.16B | 1.57% | 2,140,948 | - |
| 168 | IVA | Inventiva S.A. | 1.12B | 1.89% | 811,200 | 7.94M |
| 169 | SLDB | Solid Biosciences Inc. | 1.10B | 4.10% | 894,271 | - |
| 170 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -0.23% | 126,348 | - |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.04B | 2.06% | 988,015 | 59.00K |
| 172 | GERN | Geron Corporation | 1.02B | 7.43% | 26,890,024 | 204.56M |
| 173 | FTH | Faeth Therapeutics, Inc. | 1.01B | 13.36% | 575,116 | - |
| 174 | CADL | Candel Therapeutics, Inc. | 1.01B | 2.72% | 807,852 | - |
| 175 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 2,975,767 | 181.72M |
| 176 | IMMX | Immix Biopharma, Inc. | 998.69M | -0.36% | 1,578,211 | - |
| 177 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | 2.28% | 2,335,861 | 41.47M |
| 178 | ATTO | Attovia Therapeutics, Inc. | 995.26M | 4.10% | 81,463 | 1.35M |
| 179 | DSGN | Design Therapeutics, Inc. | 971.89M | 2.58% | 1,003,358 | - |
| 180 | WVE | Wave Life Sciences, Inc. | 961.60M | -1.81% | 5,479,191 | 65.37M |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 947.60M | 2.56% | 866,429 | - |
| 182 | ARDX | Ardelyx, Inc. | 946.91M | 1.06% | 3,913,812 | 450.89M |
| 183 | SGP | SpyGlass Pharma, Inc. | 945.91M | 5.29% | 113,499 | - |
| 184 | ANNX | Annexon, Inc. | 934.63M | 0.82% | 1,842,213 | - |
| 185 | RIGL | Rigel Pharmaceuticals, Inc. | 923.16M | 4.04% | 184,700 | 276.79M |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 909.69M | 2.66% | 1,550,403 | 8.22M |
| 187 | ANL | Adlai Nortye Group Ltd. | 892.23M | 1.65% | 77,708 | 18.06M |
| 188 | SLN | Silence Therapeutics plc | 890.50M | 0.34% | 634,202 | 615.00K |
| 189 | TBPH | Theravance Biopharma, Inc. | 886.25M | 0.23% | 566,897 | 104.31M |
| 190 | HELP | Cybin Inc. | 873.07M | 3.02% | 2,116,648 | - |
| 191 | ACHV | Achieve Life Sciences, Inc. | 872.61M | 2.79% | 1,044,381 | - |
| 192 | CLYM | Climb Bio, Inc. | 864.42M | 1.55% | 2,214,698 | - |
| 193 | FDMT | 4D Molecular Therapeutics, Inc. | 825.35M | 4.11% | 1,036,430 | 92.01M |
| 194 | DBVT | DBV Technologies S.A. | 813.62M | 1.42% | 185,679 | 5.04M |
| 195 | CTMX | CytomX Therapeutics, Inc. | 810.59M | 1.36% | 6,497,409 | 18.30M |
| 196 | PHAR | Pharming Group N.V. | 796.14M | 0.81% | 4,987 | 366.48M |
| 197 | CBIO | Crescent Biopharma, Inc. | 793.53M | 3.40% | 214,874 | 11.88M |
| 198 | MNPR | Monopar Therapeutics Inc. | 780.49M | -1.10% | 203,352 | - |
| 199 | NVCT | Nuvectis Pharma, Inc. | 779.35M | 3.73% | 188,613 | - |
| 200 | AURA | Aura Biosciences, Inc. | 777.79M | 0.94% | 495,494 | - |
| 201 | NGNE | Neurogene Inc. | 767.64M | 1.29% | 252,962 | 925.00K |
| 202 | ASMB | Assembly Biosciences, Inc. | 747.64M | 4.38% | 267,541 | 74.85M |
| 203 | OCS | Oculis Holding AG | 742.02M | -1.31% | 183,088 | 1.45M |
| 204 | PHAT | Phathom Pharmaceuticals, Inc. | 735.52M | -1.38% | 932,647 | 239.66M |
| 205 | OABI | OmniAb, Inc. | 732.77M | 13.51% | 5,084,227 | 38.46M |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 730.42M | 1.99% | 1,347,750 | 136.07M |
| 207 | VSTM | Verastem, Inc. | 726.32M | 5.39% | 5,260,669 | 87.53M |
| 208 | MPLT | MapLight Therapeutics, Inc. | 725.82M | -1.88% | 937,694 | - |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 712.75M | 0.79% | 238,880 | - |
| 210 | DRUG | Bright Minds Biosciences Inc. | 705.94M | 0.40% | 67,013 | - |
| 211 | STTK | Shattuck Labs, Inc. | 693.51M | 0.58% | 583,527 | 1.00M |
| 212 | ALLO | Allogene Therapeutics, Inc. | 684.07M | -0.25% | 5,393,709 | 4.64M |
| 213 | SGMT | Sagimet Biosciences Inc. | 683.12M | 4.67% | 1,801,035 | - |
| 214 | GYRE | Gyre Therapeutics, Inc. | 674.37M | -1.70% | 58,067 | 109.82M |
| 215 | AGMB | AgomAb Therapeutics NV | 672.73M | 0.89% | 158,852 | - |
| 216 | CRMD | CorMedix Inc. | 671.10M | 2.74% | 1,102,064 | 462.25M |
| 217 | MDXG | MiMedx Group, Inc. | 663.21M | 0.66% | 1,040,316 | 355.17M |
| 218 | VALN | Valneva SE | 656.63M | 8.37% | 137,179 | 163.30M |
| 219 | PRME | Prime Medicine, Inc. | 652.91M | 2.80% | 2,473,918 | 4.07M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 648.59M | 4.17% | 298,619 | - |
| 221 | ALT | Altimmune, Inc. | 638.02M | 6.15% | 7,472,170 | 31.00K |
| 222 | RGNX | REGENXBIO Inc. | 633.73M | 3.00% | 866,268 | 174.48M |
| 223 | ARVN | Arvinas, Inc. | 627.05M | 3.34% | 548,800 | 316.70M |
| 224 | EIKN | Eikon Therapeutics, Inc. | 616.40M | 4.60% | 553,420 | - |
| 225 | CABA | Cabaletta Bio, Inc. | 605.28M | 8.18% | 8,049,185 | - |
| 226 | AUTL | Autolus Therapeutics plc | 596.20M | -3.03% | 2,307,871 | 117.39M |
| 227 | TECX | Tectonic Therapeutic, Inc. | 593.91M | -2.69% | 167,350 | - |
| 228 | BLSM | BlossomHill Therapeutics, Inc. | 593.87M | 2.05% | 109,689 | - |
| 229 | SCTX | Scribe Therapeutics Inc. | 582.91M | 6.55% | 278,713 | 36.28M |
| 230 | SPRY | ARS Pharmaceuticals, Inc. | 578.78M | 0.87% | 1,196,979 | 116.93M |
| 231 | PROK | ProKidney Corp. | 577.44M | 3.24% | 641,215 | 818.00K |
| 232 | CAPR | Capricor Therapeutics, Inc. | 574.99M | -1.20% | 5,165,484 | 11.13M |
| 233 | PRLD | Prelude Therapeutics Incorporated | 559.26M | -1.09% | 355,094 | 22.42M |
| 234 | ARTV | Artiva Biotherapeutics, Inc. | 552.95M | 0.27% | 306,518 | 251.00K |
| 235 | ZURA | Zura Bio Limited | 543.35M | 0.35% | 934,603 | - |
| 236 | KYTX | Kyverna Therapeutics, Inc. | 532.78M | 3.17% | 599,971 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 529.26M | -1.81% | 1,555,885 | 1.58M |
| 238 | ENTX | Entera Bio Ltd. | 505.57M | 0.69% | 143,497 | 42.00K |
| 239 | PBYI | Puma Biotechnology, Inc. | 500.20M | 3.64% | 411,940 | 231.24M |
| 240 | PRTA | Prothena Corporation plc | 497.20M | 0.78% | 341,056 | 54.53M |
| 241 | EPRX | Eupraxia Pharmaceuticals Inc. | 490.48M | 17.51% | 749,994 | - |
| 242 | RLMD | Relmada Therapeutics, Inc. | 484.28M | 1.79% | 1,416,553 | - |
| 243 | RZLT | Rezolute, Inc. | 476.37M | 1.33% | 857,320 | - |
| 244 | ARCT | Arcturus Therapeutics Holdings Inc. | 475.80M | 3.14% | 2,021,097 | 29.37M |
| 245 | DNA | Ginkgo Bioworks Holdings, Inc. | 473.40M | 1.44% | 1,269,794 | 132.42M |
| 246 | EDIT | Editas Medicine, Inc. | 473.03M | 0.33% | 1,678,516 | 47.01M |
| 247 | CCCC | C4 Therapeutics, Inc. | 466.27M | -2.07% | 1,835,390 | 35.04M |
| 248 | AVIR | Atea Pharmaceuticals, Inc. | 457.17M | 3.83% | 289,921 | - |
| 249 | IKT | Inhibikase Therapeutics, Inc. | 455.19M | 5.04% | 379,048 | 1.00 |
| 250 | EVMN | Evommune, Inc. | 452.93M | - | 370,577 | 10.00M |
| 251 | GALT | Galectin Therapeutics Inc. | 451.81M | 7.43% | 460,696 | - |
| 252 | OCGN | Ocugen, Inc. | 447.63M | -0.75% | 4,284,877 | 4.58M |
| 253 | VOGX | Vogenx, Inc. | 446.75M | -3.11% | 229,966 | - |
| 254 | BNTC | Benitec Biopharma Inc. | 442.48M | 4.63% | 191,440 | - |
| 255 | CMPX | Compass Therapeutics, Inc. | 437.61M | 5.19% | 2,539,820 | 850.00K |
| 256 | FENC | Fennec Pharmaceuticals Inc. | 431.68M | 2.33% | 292,041 | 59.22M |
| 257 | RCKT | Rocket Pharmaceuticals, Inc. | 423.73M | 3.49% | 1,164,990 | - |
| 258 | VTVT | vTv Therapeutics Inc. | 414.99M | 4.54% | 39,757 | 36.84M |
| 259 | EYPT | EyePoint, Inc. | 412.96M | 4.59% | 4,716,140 | 2.79M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 410.38M | 4.29% | 251,784 | 65.26M |
| 261 | QTTB | Q32 Bio Inc. | 404.57M | -5.36% | 434,820 | 53.74M |
| 262 | LRMR | Larimar Therapeutics, Inc. | 403.96M | -1.78% | 515,555 | - |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 400.55M | -0.74% | 360,955 | 15.85M |
| 264 | LXEO | Lexeo Therapeutics, Inc. | 392.16M | 1.70% | 468,358 | - |
| 265 | IPSC | Century Therapeutics, Inc. | 382.07M | 3.94% | 465,903 | 109.16M |
| 266 | IRD | Opus Genetics, Inc. | 370.22M | 16.19% | 4,998,100 | 9.86M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 366.47M | 2.92% | 56,859 | 27.00K |
| 268 | AGEN | Agenus Inc. | 364.22M | 1.25% | 663,996 | 132.69M |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 364.00M | 4.65% | 175,978 | - |
| 270 | ZNTL | Zentalis Pharmaceuticals, Inc. | 356.91M | 1.62% | 897,802 | 26.87M |
| 271 | UPB | Upstream Bio, Inc. | 354.92M | -1.07% | 515,756 | 3.16M |
| 272 | PALI | Palisade Bio, Inc. | 346.80M | 1.53% | 731,450 | 500.00K |
| 273 | SABS | SAB Biotherapeutics, Inc. | 341.20M | 1.35% | 300,420 | 114.70K |
| 274 | ABEO | Abeona Therapeutics Inc. | 340.24M | -0.50% | 1,088,631 | 25.52M |
| 275 | STRO | Sutro Biopharma, Inc. | 339.42M | -1.68% | 134,544 | 45.70M |
| 276 | IFRX | InflaRx N.V. | 337.47M | 6.02% | 572,037 | -11.54K |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 334.36M | 2.03% | 621,096 | 215.72M |
| 278 | SION | Sionna Therapeutics, Inc. | 330.50M | 13.16% | 1,590,547 | - |
| 279 | IMRX | Immuneering Corporation | 324.78M | 3.51% | 678,701 | - |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 313.67M | 1.54% | 19,572 | 412.09K |
| 281 | PYXS | Pyxis Oncology, Inc. | 312.78M | 9.01% | 731,710 | 11.04M |
| 282 | FHTX | Foghorn Therapeutics Inc. | 307.02M | -9.14% | 956,827 | 36.74M |
| 283 | ALEC | Alector, Inc. | 303.71M | 13.33% | 1,672,778 | 13.86M |
| 284 | PRQR | ProQR Therapeutics N.V. | 303.41M | 1.42% | 389,554 | 21.05M |
| 285 | CUVL | Clinuvel Pharmaceuticals Limited | 302.34M | -0.64% | 34,421 | 65.05M |
| 286 | BCYC | Bicycle Therapeutics plc | 300.97M | 4.88% | 317,574 | 61.21M |
| 287 | OBIO | Orchestra BioMed Holdings, Inc. | 297.52M | 1.02% | 240,380 | 31.98M |
| 288 | FULC | Fulcrum Therapeutics, Inc. | 293.74M | -0.52% | 1,633,567 | 80.00M |
| 289 | FATE | Fate Therapeutics, Inc. | 293.56M | 0.82% | 1,218,924 | 6.49M |
| 290 | TTRX | Turn Therapeutics Inc. | 288.05M | -1.53% | 106,478 | - |
| 291 | ALXO | ALX Oncology Holdings Inc. | 287.62M | 5.05% | 855,107 | - |
| 292 | ACIU | AC Immune SA | 282.37M | 5.97% | 257,176 | 21.67M |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 280.73M | 2.78% | 675,975 | 13.08M |
| 294 | MGNX | MacroGenics, Inc. | 275.18M | 6.93% | 581,704 | 175.14M |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 274.72M | -2.37% | 128,989 | 1.48M |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 268.51M | 1.73% | 138,967 | 7.15M |
| 297 | AVXL | Anavex Life Sciences Corp. | 267.89M | 0.70% | 587,454 | - |
| 298 | SRZN | Surrozen, Inc. | 265.63M | 1.80% | 116,907 | 11.51M |
| 299 | YDES | YD Bio Limited | 264.40M | -0.40% | 567,671 | 510.36K |
| 300 | TRDA | Entrada Therapeutics, Inc. | 263.22M | 3.25% | 306,543 | 4.69M |
| 301 | NMRA | Neumora Therapeutics, Inc. | 259.30M | 3.76% | 532,233 | - |
| 302 | NAGE | Niagen Bioscience, Inc. | 251.36M | 1.28% | 308,574 | 129.08M |
| 303 | NGEN | NervGen Pharma Corp. | 250.53M | 0.43% | 383,487 | - |
| 304 | CGEN | Compugen Ltd. | 249.12M | 1.54% | 127,919 | 74.00M |
| 305 | ADAG | Adagene Inc. | 247.76M | 1.37% | 102,671 | 9.29M |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 243.21M | -0.66% | 1,224,309 | - |
| 307 | RNA | Atrium Therapeutics, Inc. | 240.51M | 2.11% | 111,641 | 35.84M |
| 308 | CLLS | Cellectis S.A. | 239.49M | -1.52% | 7,304 | 63.82M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 238.46M | 0.26% | 215,204 | 4.22M |
| 310 | IVVD | Invivyd, Inc. | 236.99M | -8.63% | 4,994,099 | 58.37M |
| 311 | TARA | Protara Therapeutics, Inc. | 232.84M | 1.03% | 335,411 | - |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 231.03M | 4.86% | 104,021 | - |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 230.59M | 1.31% | 97,700 | 1.80M |
| 314 | TNXP | Tonix Pharmaceuticals Holding Corp. | 229.48M | -4.29% | 421,419 | 29.10M |
| 315 | ANTX | AN2 Therapeutics, Inc. | 224.53M | 8.58% | 353,562 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 224.18M | 6.16% | 247,820 | - |
| 317 | KROS | Keros Therapeutics, Inc. | 222.66M | 1.45% | 97,971 | 15.01M |
| 318 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 222.04M | 1.77% | 664,446 | - |
| 319 | PEPG | PepGen Inc. | 220.25M | 1.92% | 354,292 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 219.39M | 3.65% | 621,492 | 50.94M |
| 321 | VYGR | Voyager Therapeutics, Inc. | 218.13M | 3.21% | 435,034 | 34.46M |
| 322 | NERV | Minerva Neurosciences, Inc. | 213.91M | - | 82,826 | - |
| 323 | ORMP | Oramed Pharmaceuticals Inc. | 210.90M | 4.54% | 188,608 | 2.00M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 208.68M | - | 454,863 | 80.62M |
| 325 | NBP | NovaBridge Biosciences | 207.64M | 3.47% | 183,462 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 205.63M | -2.49% | 358,922 | 45.06M |
| 327 | ARMP | Armata Pharmaceuticals, Inc. | 205.62M | 4.73% | 70,066 | 5.54M |
| 328 | ACOG | Alpha Cognition Inc. | 202.86M | 1.58% | 55,605 | 15.26M |
| 329 | NKTX | Nkarta, Inc. | 198.04M | 2.41% | 489,637 | - |
| 330 | IPHA | Innate Pharma S.A. | 195.97M | 2.36% | 17,405 | 10.57M |
| 331 | CUE | Cue Biopharma, Inc. | 195.85M | -5.20% | 127,874 | 37.66M |
| 332 | VRXA | Veraxa Biotech AG | 195.14M | -1.43% | 176,250 | 29.54K |
| 333 | IMUX | Immunic, Inc. | 194.30M | -2.33% | 225,158 | - |
| 334 | MSLE | Satellos Bioscience Inc. | 193.15M | -0.33% | 10,800 | - |
| 335 | LENZ | LENZ Therapeutics, Inc. | 182.24M | 10.90% | 993,294 | 21.48M |
| 336 | KRRO | Korro Bio, Inc. | 176.27M | -2.21% | 81,069 | 2.38M |
| 337 | CNTB | Connect Biopharma Holdings Limited | 173.81M | 16.95% | 2,613,119 | 2.95M |
| 338 | CRBU | Caribou Biosciences, Inc. | 171.53M | 3.23% | 770,671 | 10.04M |
| 339 | SPRB | Spruce Biosciences, Inc. | 171.49M | 7.32% | 268,135 | 697.00K |
| 340 | MDWD | MediWound Ltd. | 168.61M | 3.49% | 104,152 | 11.86M |
| 341 | MENS | Jyong Biotech Ltd. | 167.03M | -0.88% | 53,483 | - |
| 342 | MIST | Milestone Pharmaceuticals Inc. | 166.27M | 3.51% | 767,736 | 2.34M |
| 343 | CNTN | Canton Strategic Holdings, Inc. | 165.74M | -8.77% | 718,254 | 1.50M |
| 344 | HUMA | Humacyte, Inc. | 165.73M | 4.59% | 5,178,828 | 2.12M |
| 345 | CDXS | Codexis, Inc. | 161.52M | -2.32% | 998,035 | 77.68M |
| 346 | MOLN | Molecular Partners AG | 159.79M | -5.02% | 282 | 856.30K |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 156.80M | 2.03% | 1,213,509 | 1.34M |
| 348 | INDP | Indaptus Therapeutics, Inc. | 155.89M | 3.54% | 331,831 | - |
| 349 | OTLK | Outlook Therapeutics, Inc. | 152.47M | 0.51% | 4,607,304 | -1.16M |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 149.69M | 0.58% | 418,342 | 3.39M |
| 351 | CNXU | Conexeu Sciences Inc. | 148.78M | -5.28% | 225,381 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 144.57M | 2.77% | 760,474 | - |
| 353 | KZIA | Kazia Therapeutics Limited | 144.09M | -0.16% | 360,968 | 1.27M |
| 354 | OKUR | OnKure Therapeutics, Inc. | 143.36M | -0.56% | 127,420 | - |
| 355 | EQ | Equillium, Inc. | 142.67M | 2.04% | 101,244 | 4.39M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 140.62M | 2.26% | 4,425,305 | 65.34K |
| 357 | BMEA | Biomea Fusion, Inc. | 140.26M | 7.50% | 2,136,579 | - |
| 358 | HURA | TuHURA Biosciences, Inc. | 133.19M | 2.96% | 139,137 | - |
| 359 | AARD | Aardvark Therapeutics, Inc. | 130.21M | 0.51% | 59,406 | - |
| 360 | VANI | Vivani Medical, Inc. | 128.09M | 4.41% | 143,169 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 126.61M | 1.89% | 1,061,723 | - |
| 362 | PMN | ProMIS Neurosciences, Inc. | 125.32M | 4.68% | 89,672 | - |
| 363 | NTHI | NeOnc Technologies Holdings, Inc. | 123.29M | 4.86% | 151,327 | 39.99K |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 122.95M | 4.90% | 561,276 | 70.00M |
| 365 | NAUT | Nautilus Biotechnology, Inc. | 122.39M | 3.81% | 836,131 | 190.00K |
| 366 | TLSA | Tiziana Life Sciences Ltd | 120.45M | -3.33% | 488,443 | - |
| 367 | RANI | Rani Therapeutics Holdings, Inc. | 119.60M | -0.75% | 426,670 | 4.88M |
| 368 | CBUS | Cibus, Inc. | 119.23M | - | 95,095 | 4.35M |
| 369 | GNLX | Genelux Corporation | 114.27M | -1.92% | 158,138 | 8.00K |
| 370 | RNXT | RenovoRx, Inc. | 113.73M | 19.43% | 4,134,707 | 1.98M |
| 371 | GUTS | Fractyl Health, Inc. | 112.49M | -0.20% | 2,654,042 | 3.00K |
| 372 | ONCY | Oncolytics Biotech Inc. | 112.21M | 4.76% | 1,587,978 | - |
| 373 | SEER | Seer, Inc. | 109.64M | 2.06% | 121,185 | 14.22M |
| 374 | PYPD | PolyPid Ltd. | 107.65M | -0.56% | 143,786 | - |
| 375 | ANIX | Anixa Biosciences, Inc. | 106.49M | -4.57% | 335,027 | - |
| 376 | TENX | Tenax Therapeutics, Inc. | 105.97M | 2.78% | 3,702,050 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 103.68M | -2.00% | 61,903 | 8.02M |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 101.69M | 3.03% | 32,825 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 99.85M | 3.96% | 378,403 | - |
| 380 | ACET | Adicet Bio, Inc. | 99.68M | - | 60,955 | - |
| 381 | PTHS | Pelthos Therapeutics Inc. | 95.83M | 0.85% | 87,878 | 43.30M |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 94.76M | 4.66% | 20,899 | 6.19M |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 92.84M | -0.51% | 17,271 | - |
| 384 | VRCA | Verrica Pharmaceuticals Inc. | 92.59M | 2.86% | 31,077 | 30.32M |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 92.13M | 3.86% | 131,319 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 91.05M | 1.87% | 279,774 | 68.47M |
| 387 | ICCC | ImmuCell Corporation | 90.82M | 0.81% | 16,279 | 30.68M |
| 388 | RLYB | Rallybio Corporation | 89.96M | 1.50% | 29,840 | 646.00K |
| 389 | ALDX | Aldeyra Therapeutics, Inc. | 89.89M | - | 498,451 | - |
| 390 | OKYO | OKYO Pharma Limited | 85.02M | 7.28% | 91,526 | - |
| 391 | GOSS | Gossamer Bio, Inc. | 84.42M | 3.17% | 5,758,056 | 53.29M |
| 392 | DWTX | Dogwood Therapeutics, Inc. | 84.30M | -5.70% | 50,418 | - |
| 393 | IBIO | iBio, Inc. | 84.24M | 3.97% | 311,034 | 100.00K |
| 394 | YARW | Yarrow Bioscience, Inc. | 83.94M | -3.23% | 33,985 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 83.33M | 5.38% | 865,839 | - |
| 396 | CRDF | Cardiff Oncology, Inc. | 82.46M | 2.91% | 701,874 | 508.00K |
| 397 | ATHE | Alterity Therapeutics Limited | 81.48M | -0.66% | 7,364 | 2.50M |
| 398 | OSTX | OS Therapies Incorporated | 78.88M | 3.01% | 530,467 | - |
| 399 | GANX | Gain Therapeutics, Inc. | 78.12M | 1.13% | 367,690 | - |
| 400 | TELO | Telomir Pharmaceuticals, Inc. | 77.03M | 1.82% | 31,382 | - |
| 401 | CING | Cingulate Inc. | 74.89M | 0.78% | 83,578 | - |
| 402 | NRXS | NeurAxis, Inc. | 74.72M | 2.41% | 79,693 | 5.32M |
| 403 | ANVS | Annovis Bio, Inc. | 72.43M | 0.59% | 606,826 | - |
| 404 | LONA | LeonaBio, Inc. | 72.26M | 1.05% | 5,702 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 71.83M | 4.50% | 740,064 | - |
| 406 | CSBR | Champions Oncology, Inc. | 71.55M | 3.00% | 9,241 | 59.43M |
| 407 | SPRO | Spero Therapeutics, Inc. | 71.05M | 1.67% | 169,514 | 47.00M |
| 408 | MNOV | MediciNova, Inc. | 70.39M | -0.69% | 14,305 | 920.48K |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 67.36M | -2.33% | 704,362 | - |
| 410 | ELTX | Elicio Therapeutics, Inc. | 67.02M | -0.39% | 397,648 | - |
| 411 | RNTX | Rein Therapeutics Inc. | 66.84M | 2.94% | 489,076 | - |
| 412 | XBIT | XBiotech Inc. | 66.77M | -1.35% | 109,028 | - |
| 413 | SER | Serina Therapeutics, Inc. | 66.55M | 4.80% | 70,946 | 130.00K |
| 414 | BOLD | Boundless Bio, Inc. | 65.74M | - | 81,534 | - |
| 415 | INMB | INmune Bio Inc. | 65.22M | 4.91% | 171,014 | 50.00K |
| 416 | EDSA | Edesa Biotech, Inc. | 64.31M | -0.42% | 29,813 | - |
| 417 | ELOX | Eloxx Pharmaceuticals, Inc. | 63.94M | 5.53% | 57,780 | - |
| 418 | ALPS | Alps Group Inc | 63.23M | -2.44% | 66,837 | 3.74M |
| 419 | BSEM | BioStem Technologies, Inc. | 63.19M | 1.14% | 60,758 | 34.59M |
| 420 | EXOZ | eXoZymes, Inc. | 63.02M | 4.46% | 926 | -700.00 |
| 421 | HYFT | MindWalk Holdings Corp. | 62.73M | 2.69% | 57,796 | 11.43M |
| 422 | APLM | Apollomics, Inc. | 60.05M | 1.51% | 11,661 | 8.84M |
| 423 | HRTX | Heron Therapeutics, Inc. | 59.40M | -0.67% | 2,170,209 | 151.18M |
| 424 | XLO | Xilio Therapeutics, Inc. | 58.17M | -0.45% | 4,654 | 64.09M |
| 425 | INKT | MiNK Therapeutics, Inc. | 57.82M | 3.47% | 8,261 | - |
| 426 | NTRB | Nutriband Inc. | 57.13M | 8.17% | 29,311 | 1.80M |
| 427 | IMA | ImageneBio, Inc. | 56.30M | -1.20% | 6,244 | 800.00K |
| 428 | MCRB | Seres Therapeutics, Inc. | 55.07M | 6.95% | 63,656 | 1.88M |
| 429 | CELU | Celularity Inc. | 53.84M | -1.06% | 654,741 | 26.55M |
| 430 | IBO | Impact BioMedical Inc. | 52.83M | 6.99% | 45,116 | 35.00K |
| 431 | TIL | Instil Bio, Inc. | 52.12M | -0.07% | 3,883 | - |
| 432 | IMMP | Immutep Limited | 51.79M | 3.15% | 118,506 | 13.79M |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 48.52M | 4.26% | 1,307,503 | 21.00M |
| 434 | ATYR | aTyr Pharma, Inc. | 48.36M | 3.46% | 700,089 | 190.00K |
| 435 | HYPD | Hyperion DeFi, Inc. | 47.55M | -0.81% | 309,948 | 1.40M |
| 436 | VERU | Veru Inc. | 46.89M | 2.23% | 202,595 | 16.89M |
| 437 | TVGN | Tevogen Inc. | 46.69M | - | 1,507 | - |
| 438 | GRCE | Grace Therapeutics, Inc. | 45.02M | 1.90% | 48,983 | - |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 43.82M | -0.85% | 313,107 | 13.56M |
| 440 | MREO | Mereo BioPharma Group plc | 42.67M | -3.43% | 809,248 | 500.00K |
| 441 | FLNA | Filana Therapeutics, Inc. | 41.43M | 0.03% | 347,809 | - |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 40.60M | -3.24% | 1,296,285 | 146.62M |
| 443 | CRVO | CervoMed Inc. | 39.91M | 2.72% | 134,532 | 331.30K |
| 444 | ALGS | Aligos Therapeutics, Inc. | 38.78M | 1.97% | 55,406 | 31.52M |
| 445 | LITS | Lite Strategy, Inc. | 35.39M | 4.63% | 71,060 | - |
| 446 | KYNB | Kyntra Bio, Inc. | 34.54M | 7.30% | 42,193 | 4.62M |
| 447 | RNAZ | TransCode Therapeutics, Inc. | 34.03M | -2.43% | 22,515 | - |
| 448 | NXTC | NextCure, Inc. | 33.64M | 8.09% | 112,640 | - |
| 449 | CNTX | Context Therapeutics Inc. | 33.32M | -0.44% | 1,317,853 | - |
| 450 | QNCX | Quince Therapeutics, Inc. | 32.70M | 0.12% | 15,484 | - |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 31.44M | 0.45% | 77,575 | 35.09M |
| 452 | ACTU | Actuate Therapeutics, Inc. | 31.22M | -15.58% | 335,528 | - |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.12M | -1.65% | 95,405 | - |
| 454 | IGC | IGC Pharma, Inc. | 30.59M | -0.27% | 458,196 | 1.11M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 30.35M | -2.88% | 190,951 | 14.97M |
| 456 | ESLA | Estrella Immunopharma, Inc. | 30.01M | -0.22% | 17,453 | - |
| 457 | CVM | CEL-SCI Corporation | 29.02M | 2.48% | 134,714 | - |
| 458 | RADX | Radiopharm Theranostics Limited | 28.00M | -4.85% | 11,007 | 9.34M |
| 459 | NNVC | NanoViricides, Inc. | 26.65M | -3.31% | 502,947 | - |
| 460 | TCRX | TScan Therapeutics, Inc. | 25.83M | -42.80% | 8,517,352 | 7.11M |
| 461 | EVAX | Evaxion A/S | 25.60M | 3.02% | 60,661 | 7.49M |
| 462 | QNTM | Quantum BioPharma Ltd. | 25.42M | 1.32% | 51,426 | - |
| 463 | BYSI | BeyondSpring Inc. | 25.12M | 1.39% | 40,318 | 1.88M |
| 464 | TVRD | Tvardi Therapeutics, Inc. | 25.08M | 7.74% | 107,886 | - |
| 465 | LTRN | Lantern Pharma Inc. | 24.67M | -4.46% | 162,611 | - |
| 466 | ATOS | Atossa Therapeutics, Inc. | 24.55M | 1.65% | 44,772 | - |
| 467 | GRDX | GridAI Technologies Corp. | 24.50M | -3.35% | 110,911 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 23.46M | 1.05% | 380,351 | - |
| 469 | PLRZ | Polyrizon Ltd. | 23.42M | -12.88% | 133,771 | - |
| 470 | GNTA | Genenta Science S.p.A. | 23.07M | -3.16% | 23,447 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 22.97M | -1.22% | 48,767 | - |
| 472 | ALLR | Allarity Therapeutics, Inc. | 22.43M | -0.70% | 124,371 | 345.00K |
| 473 | ABVC | ABVC BioPharma, Inc. | 22.41M | 4.74% | 138,162 | 797.92K |
| 474 | COCP | Cocrystal Pharma, Inc. | 22.35M | 3.57% | 56,684 | 330.00K |
| 475 | CNSY | Cerenome, Inc. | 22.31M | 8.49% | 61,113 | 4.20M |
| 476 | PTN | Palatin Technologies, Inc. | 22.21M | 11.27% | 311,126 | 12.88M |
| 477 | ENLV | Enlivex Ltd. | 21.86M | -2.34% | 227,500 | - |
| 478 | LEXX | Lexaria Bioscience Corp. | 21.82M | 5.81% | 40,951 | 194.00K |
| 479 | LGVN | Longeveron Inc. | 21.62M | 0.44% | 36,041 | 1.19M |
| 480 | MRKR | Marker Therapeutics, Inc. | 20.84M | -3.85% | 167,577 | 3.55M |
| 481 | CYCN | Cyclerion Therapeutics, Inc. | 20.83M | 8.39% | 114,265 | 1.90M |
| 482 | NEUP | Neuphoria Therapeutics Inc. | 20.27M | -1.06% | 17,947 | -13.27K |
| 483 | CMMB | Chemomab Therapeutics Ltd. | 19.78M | - | 47,823 | - |
| 484 | AKTX | Akari Therapeutics, Plc | 19.76M | -2.12% | 46,499 | - |
| 485 | NIKI | Niki BioSolutions, Inc. | 19.42M | -0.15% | 31,273 | - |
| 486 | LPCN | Lipocine Inc. | 19.42M | 2.39% | 35,051 | 1.57M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 19.39M | 3.07% | 225,753 | - |
| 488 | NCEL | NewcelX Ltd. | 19.35M | 1.82% | 3,508 | - |
| 489 | DYAI | Dyadic International, Inc. | 19.10M | -1.48% | 124,861 | 3.80M |
| 490 | TPST | Tempest Therapeutics, Inc. | 17.58M | 4.76% | 127,697 | - |
| 491 | BCDA | BioCardia, Inc. | 16.80M | 0.91% | 50,969 | 3.00K |
| 492 | PBM | Psyence Biomedical Ltd. | 16.67M | - | 21,400 | - |
| 493 | ADIL | Adial Pharmaceuticals, Inc. | 16.60M | 6.22% | 53,787 | - |
| 494 | CTXR | Citius Pharmaceuticals, Inc. | 15.91M | 1.83% | 223,905 | 7.11M |
| 495 | PLUR | Pluri Inc. | 15.32M | -2.74% | 37,729 | 1.08M |
| 496 | BIVI | BioVie Inc. | 15.31M | -9.38% | 519,400 | - |
| 497 | HIND | Vyome Holdings, Inc. | 15.30M | 0.46% | 4,404 | 129.73K |
| 498 | NRSN | NeuroSense Therapeutics Ltd. | 15.19M | -2.21% | 212,074 | - |
| 499 | PASG | Passage Bio, Inc. | 14.83M | 3.83% | 3,437 | - |
| 500 | CALC | CalciMedica, Inc. | 14.34M | 5.00% | 113,722 | - |